Dedee Murrell

Professor Dedee Murrell completed medical training at Cambridge and Oxford Universities, 3 years of internal medicine in the UK and USA, dermatology training at UNC-Chapel Hill, a fellowship in dermatopharmacology at Duke, blistering diseases and cell biology at New York University, and then became a clinical scholar at Rockefeller University. She holds a doctorate on the pathogenesis of blistering disorders, her main subspecialty interest, and her current research focusses on the development and validation of clinical outcome measures for autoimmune blistering diseases and epidermolysis bullosa to enable clinical trials to proceed in these orphan diseases. She has 418 peer reviewed papers, 16,7500 citations, an H index of 61, i!) of 213 and has edited 6 books, including the textbook, Blistering Diseases. She lectures at international congresses regularly and is a visiting professor in 5 continents. She was Congress President of the ICD 2021, the world’s first virtual Dermathon. She was founding Co-Editor of the International Journal of Women’s Dermatology and serves on the editorial boards of BJD, JAMA Dermatology, International Journal of Dermatology, JEADV, Acta Dermatovenereologica and JAAD International. She established Australia’s first dedicated dermatology clinical trial centre and is a KOL in trial design and conduct, serving on numerous advisory boards for more than 20 years. Her group established the ABQOL/TABQOL for measuring QOL in AIBD and she co-led the development and validation of the PDAI, BPDAI and MMPDAI. She established the Australasian Blistering Diseases Foundation in 2006.